Materials Healthcare Sector

Absci

Market Cap: US$377.6m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

AngioDynamics

Market Cap: US$372.4m

A medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.

COMPASS Pathways

Market Cap: US$369.6m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

ClearPoint Neuro

Market Cap: US$361.5m

Operates as a medical device company primarily in the United States.

Prothena

Market Cap: US$361.4m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Zhengye Biotechnology Holding

Market Cap: US$361.1m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

SBC Medical Group Holdings

Market Cap: US$360.6m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Erasca

Market Cap: US$359.8m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

NIOX Group

Market Cap: UK£270.1m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Senseonics Holdings

Market Cap: US$358.4m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

Fulcrum Therapeutics

Market Cap: US$356.3m

A clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States.

Rapport Therapeutics

Market Cap: US$356.0m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

MBX Biosciences

Market Cap: US$356.0m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

TruBridge

Market Cap: US$355.8m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

Faron Pharmaceuticals Oy

Market Cap: UK£267.9m

Operates as a clinical stage drug discovery and development company.

Semler Scientific

Market Cap: US$354.5m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Oruka Therapeutics

Market Cap: US$354.2m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Rigel Pharmaceuticals

Market Cap: US$352.8m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Alpha Teknova

Market Cap: US$347.9m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Checkpoint Therapeutics

Market Cap: US$347.6m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Nano-X Imaging

Market Cap: US$347.5m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Humacyte

Market Cap: US$347.5m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Mereo BioPharma Group

Market Cap: US$346.6m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Outset Medical

Market Cap: US$346.5m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

Benitec Biopharma

Market Cap: US$344.2m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Clinuvel Pharmaceuticals

Market Cap: AU$535.6m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Autolus Therapeutics

Market Cap: US$343.3m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Cytek Biosciences

Market Cap: US$339.4m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

TurnKey Capital

Market Cap: US$338.5m

HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

Mayne Pharma Group

Market Cap: AU$526.5m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Cryoport

Market Cap: US$337.4m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

ORIC Pharmaceuticals

Market Cap: US$337.0m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Atai Life Sciences

Market Cap: US$329.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

SNDL

Market Cap: US$329.3m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Varex Imaging

Market Cap: US$327.5m

Designs, manufactures, and sells X-ray imaging components.

Anbio Biotechnology

Market Cap: US$327.4m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.